JPMorgan presents its favorite drug stock ideas into earnings season.
Stephen Ubl, Pharmaceutical Research and Manufacturers of America (PhRMA) president & CEO, discusses the political rhetoric around the pharma industry and drug pricing.
Shares of Walgreen Boots Alliance and Rite Aid are trading lower after the merger of the two drugstore companies is facing US antitrust concerns.
Mexico's most notorious cartel kingpin who spent years on the run as the country's most wanted man, was extradited to the U.S. Thursday.
Jan 17- McKesson Corp, one of the largest U.S. distributors of pharmaceutical drugs, will pay a record $150 million to resolve a U.S. investigation into whether it failed to report suspicious orders of addictive painkillers. Tuesday's deal with the U.S. Justice Department followed an earlier settlement with the company over similar violations in 2008.
Peruvian authorities seized two tons of cocaine in packages that were supposed to contain only asparagus.
Discussing President-elect Trump's comments on the pharmaceutical industry with Bill George, Harvard Business School senior fellow and former Medtronic CEO.
Morgan Stanley's 2020 earnings-per-share estimate for Merck is $5.82 versus the Wall Street consensus of $4.97.
CNBC's Meg Tirrell speaks with Dr. Len Schleifer, Regeneron president & CEO, about industry's viewpoint on patients and drug pricing.
New Jersey Gov. Chris Christie will forgo the traditional formula of laying out his achievements during his final State of the State address Tuesday, reports NBC News.
Juan Sartori, president and founder of Union Group, discusses his investment in cannabis, saying that public opinion has changed towards the drug.
Jan 9- The U.S. Food and Drug Administration on Monday approved Egalet Corp's long-acting opioid painkiller, Arymo ER, and will allow the company to claim it deters abuse by those seeking to dissolve and inject it. The FDA typically follows the advice of its advisory panels but is not obliged to do so. The FDA said in a statement that an extended-release morphine...
Jan 9- The U.S. Food and Drug Administration said on Monday it has approved Egalet Corp's long-acting opioid painkiller, Arymo ER. The decision follows the recommendation of an independent panel of advisors to the FDA, which in August voted 18-1 in favor of approval. The FDA did not immediately say whether it has granted the abuse-deterrent label.
Jan 9- The U.S. Food and Drug Administration said on Monday it has approved Egalet Corp's long-acting opioid painkiller, Arymo ER. FDA in August voted 18-1 in favor of approval and recommended the drug be labeled as an abuse-deterrent product by the intravenous, nasal and oral routes of abuse. http://bit.ly/2jv97Ld. Lawmakers across the United States are...
Citi lowers its 2017 Mylan earnings-per-share estimate to $5.31 from $5.54 versus the $5.37 Wall Street consensus.
About 100 million Americans suffer from chronic pain. New FDA-approved tech devices that disrupt pain signals offer a solution.
Jan 4- Heron Therapeutics Inc on Wednesday said its experimental combination drug for post-operative pain led to significant reductions in pain intensity and the need for opioids, according to initial data from a midstage trial. Heron shares jumped more than 8 percent in extended trading after the results were released. But the gains were erased after the...
CNBC's Meg Tirrell reports on how high drug prices are limiting access to life-saving drugs such as Naloxone.
Pharmaceutical industry’s middlemen face a greater scrutiny next year, according to Breakingviews.
Mylan, Lockheed Martin, Amazon, and Wal-Mart stocks are making headlines on the last day of trading for 2016.